Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
71
datasets available to search
ShareScore release 0.9.0
Dataset results
71 results for “Lisinopril”
Figure 8 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 8 Graph of the dependence of the adsorption of the reaction product of valsartan with ninhydrin on time.
Figure 1 from: Althanoon ZA, Mahmood IH (2021) Effect of lisinopril therapy on serum leptin, oxidative stress and C-reactive protein in hypertensive patients. Pharmacia 68(3): 705-711. https://doi.org/10.3897/pharmacia.68.e73140
Figure 1 The difference in mean of measured parameters (MDA, hsCRP, TAC, and GSH) among the study sampled groups.
ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICS
ClinicalTrials.gov study NCT07177898. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
ClinicalTrials.gov study NCT00553969. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
ClinicalTrials.gov study NCT01880528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
ClinicalTrials.gov study NCT01234922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension
ClinicalTrials.gov study NCT01218100. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Progressive development of melanoma-induced cachexia differentially impacts organ systems in mice. [Lisinopril]
GEO Series GSE214981. Mus musculus. 15 samples. Type: Expression profiling by high throughput sequencing.
Scheme III from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Scheme III Suggested reaction mechanism for reaction between lisinopril and copper (II) sulfate.
Figure 6 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 6 The absorption spectra for the blue end product in terms of study Job's method.
Figure 5 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 5 Absorption spectrum of lisinopril for method II.
Figure 4 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 4 Effect of ninhydrin concentration on the absorbance at λmax of the coloured product.
Figure 3 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 3 Effect of heating time on the formation of coloured product.
Figure 2 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 2 Absorption spectrum of lisinopril for method I.
Figure 7 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 7 (A) Calibration curve (Method I) (B) Calibration curve (Method II).
Scheme I from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Scheme I Suggested reaction pathway between lisinopril and ninhydrin (Sbârcea et al. 2014).
Scheme II from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Scheme II Proposal of the reaction pathway between lisinopril and copper (II) sulfate.
Figure 1 from: Shulyak N, Budzivula K, Kucher T, Kryskiw L, Poliak O, Logoyda L (2021) Spectrophotometric methods for the determination of lisinopril in medicines. Pharmacia 68(4): 811-818. https://doi.org/10.3897/pharmacia.68.e72991
Figure 1 Chemical structure of lisinopril.
Figure 1 from: Shulyak N, Liushuk K, Semeniuk O, Yarema N, Uglyar T, Popovych D, Sverstiuk A, Ciciura R, Logoyda L (2022) Study of the dissolution kinetics of drugs in solid dosage form with lisinopril and atorvastatin and intestinal permeability to assess their equivalence in vitro. Pharmacia 69(1): 61-67. https://doi.org/10.3897/pharmacia.69.e77319
Figure 1 Typical multiple reaction monitoring chromatograms of atorvastatin.
Figure 2 from: Shulyak N, Liushuk K, Semeniuk O, Yarema N, Uglyar T, Popovych D, Sverstiuk A, Ciciura R, Logoyda L (2022) Study of the dissolution kinetics of drugs in solid dosage form with lisinopril and atorvastatin and intestinal permeability to assess their equivalence in vitro. Pharmacia 69(1): 61-67. https://doi.org/10.3897/pharmacia.69.e77319
Figure 2 Typical multiple reaction monitoring chromatograms of lisinopril.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.